Resveratrol or Higher Arterial Blood Pressure Protects the Spinal Cord From Ischemia-Reperfusion Injury?

Annals of Thoracic Surgery

Volumn 82, Issue 4, 2006, Pages 1572-1573

  Toumpoulis, Ioannis K ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE; MYELOPEROXIDASE; POLYPHENOL; RESVERATROL;

AORTA OCCLUSION; ARTERIAL PRESSURE; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVITY; HISTOPATHOLOGY; LETTER; MOTONEURON; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ISCHEMIC PRECONDITIONING; RABBITS; REPERFUSION INJURY; SPINAL CORD ISCHEMIA; STILBENES; SWINE; VASODILATOR AGENTS;

EID: 33748755543     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.04.019     Document Type: Letter

References (5)

1. Kaplan S., Bisleri G., Morgan J.A., Cheema F.H., and Oz M.C. Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury. Ann Thorac Surg 80 (2005) 2242-2249
2. Kiziltepe U., Turan N.N., Han U., Ulus A.T., and Akar F. Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 40 (2004) 138-145
3. Toumpoulis I.K., Anagnostopoulos C.E., Drossos G.E., Malamou-Mitsi V.D., Pappa L.S., and Katritsis D.G. Early ischemic preconditioning without hypotension prevents spinal cord injury caused by descending thoracic aortic occlusion. J Thorac Cardiovasc Surg 125 (2003) 1030-1036
4. Toumpoulis I.K., Papakostas J.C., Matsagas M.I., et al. Superiority of early relative to late ischemic preconditioning in spinal cord protection after descending thoracic aortic occlusion. J Thorac Cardiovasc Surg 128 (2004) 724-730
5. Kakimoto M., Kawaguchi M., Sakamoto T., et al. Evaluation of rapid ischemic preconditioning in a rabbit model of spinal cord ischemia. Anesthesiology 99 (2003) 1112-1117